Polydatin protects against lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 923-934

  Wu, M J ^a   Gong, X ^a   Jiang, R ^a   Zhang, L ^a   Li, X H ^a   Wan, Jing Yuan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Fulminant hepatic failure; Lipopolysaccharide; NF ; Polydatin; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CD31 ANTIGEN; GALACTOSAMINE; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; POLYDATIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ENDOTHELIAL CELL ADHESION MOLECULE 1; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PICEID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FULMINANT HEPATIC FAILURE; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; ANIMAL TISSUE; DRUG DOSE INCREASE; EXPERIMENTAL DISEASE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; LIPOPOLYSACCHARIDE INDUCED FULMINANT HEPATIC FAILURE; LIVER INJURY; MORTALITY;

EID: 84872895088     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500410     Document Type: Article

References (39)

1. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008; 49:845-61.
2. Possamai LA, Antoniades CG, Anstee QM, et al. Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol 2010; 16:1811-9.
3. Alam S, Azam G, Mustafa G, et al. Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west. Saudi J Gastroenterol 2009; 15:229-33.
4. Kim SH, Kim YS, Kang SS, Bae K, Hung TM, Lee SM. Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharmacol Sci 2008; 106:225-33. (Pubitemid 351366341)
5. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32:734-9.
6. Gong X, Luo FL, Zhang L, Li HZ, Wu MJ, Li XH, et al. Tetrandrine attenuates lipopolysaccharide-inducedfulminant hepatic failure in D-galactosamine sensitized mice. Int Immunopharmacol 2010; 10:357-63.
7. Pryhuber GS, Huyck HL, Roper JM, et al. Acute tumor necrosis factor-alpha-induced liver injury in the absence of tumor necrosis factor receptor-associated factor 1 gene expression. Am J Pathol 2005; 166:1637-45. (Pubitemid 40734387)
8. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290:G583-9.
9. Xiao K, Xuan L, Xu Y, Bai D, Zhong D. Constituents from Polygonum cuspidatum. Chem Pharm Bull (Tokyo) 2002; 50:605-8. (Pubitemid 41694927)
10. Zhang LP, Ma HJ, Bu HM, et al. Polydatin attenuates ischemia/reperfusion- induced apoptosis in myocardium of the rat. Sheng Li Xue Bao 2009; 61:367-72.
11. Deng YH, Alex D, Huang HQ, et al. Inhibition of TNF-alpha-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4′-trimethoxystilbene. Phytother Res 2011; 25:451-7.
12. Huang HX, Zhao Q, Jin CH. Effect of polydatin on lipopolysaccharide- induced leucocyte Chemotaxis. Di Yi Jun Yi Da Xue Xue Bao 2003; 23:1253-6.
13. Huang ZS, Wang ZW, Liu MP, Zhong SQ, Li QM, Rong XL. Protective effects of polydatin against CCl (4)-induced injury to primarily cultured rat hepatocytes. World J Gastroenterol 1999; 5:41-4.
14. Zhang H, Yu CH, Jiang YP, et al. Protective Effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice. PLoS One 2012; 7:e46574.
15. Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur J Pharmacol 2008; 587:302-8.
16. Endo Y, Shibazaki M, Yamaguchi K, et al. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol 1999; 128:5-12. (Pubitemid 29425261)
17. Tang X, Metzger D, Leeman S, Amar S. LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA 2006; 103:13777-82. (Pubitemid 44413984)
18. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76:5939-43. (Pubitemid 10216692)
19. Fotio AL, Olleros ML, Vesin D, et al. In vitro inhibition of lipopolysaccharide and mycobacterium bovis bacillus Calmette Guerin-induced inflammatory cytokines and in vivo protection from D-galactosamine/LPS -mediated liver injury by the medicinal plant Sclerocarya birrea. Int J Immunopathol Pharmacol 2010; 23:61-72.
20. Kinoshita S, Inoue Y, Nakama S, Ichiba T, Aniya Y. Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin. Phytomedicine 2007; 14:755-62. (Pubitemid 47539096)
21. Olleros ML, Vesin D, Fotio AL, et al. Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis. J Hepatol 2010; 53:1059-68.
22. Koike-Kiriyama N, Adachi Y, Iwasaki M, et al. High mortality rate of (NZW x BXSB) F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells. Clin Exp Immunol 2008; 154:285-93.
23. Wang H, Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Eur J Pharmacol 2006; 534:194-201. (Pubitemid 43384201)
24. Lesslauer W, Tabuchi H, Gentz R, et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991; 21:2883-6.
25. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749-52. (Pubitemid 29314747)
26. Salamone G, Trevani A, Martinez D, et al. Analysis of the mechanisms involved in the stimulation of neutrophil apoptosis by tumour necrosis factor-alpha. Immunology 2004; 113:355-62. (Pubitemid 39472152)
27. Cheng YJ, Yang BC, Liu MY. Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase. Environ Health Perspect 2006; 114:507-13.
28. Zhang J, Tan Y, Yao F, Zhang Q. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-alpha and SREBP-1c. Mol Med Report 2012; 6:815-20.
29. Ohira H, Abe K, Yokokawa J, et al. Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 2003; 49:1-13.
30. Steeber DA, Tedder TF. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res 2000; 22:299-317. (Pubitemid 32382242)
31. Sumagin R, Sarelius IH. TNF-alpha activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 2006; 291:H2116-25.
32. Kalogeris TJ, Laroux FS, Cockrell A, et al. Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells. Am J Physiol 1999; 276:C856-64. (Pubitemid 29211314)
33. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995; 2:493-506.
34. Breckwoldt MO, Chen JW, Stangenberg L, et al. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci U S A 2008; 105:18584-9.
35. Seo JY, Yu JH, Lim JW, Mukaida N, Kim H. Nitric oxide-induced IL-8 expression is mediated by NFkappaB and AP-1 in gastric epithelial AGS cells. J Physiol Pharmacol 2009; 60(S)7:101-6.
36. Tapalaga D, Tiegs G, Angermuller S. NFkappaB and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with TNFalpha. J Histochem Cytochem 2002; 50:1599-609. (Pubitemid 36078125)
37. Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol 2006; 72:1090-101. (Pubitemid 44465843)
38. Van Berlo D, Knaapen AM, van Schooten FJ, Schins RP, Albrecht C. NF-kappaB dependent and independent mechanisms of quartz-induced proinflammatory activation of lung epithelial cells. Part Fibre Toxicol 2010; 7:13.
39. Sasaki M, Jordan P, Welbourne T, et al. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol 2005; 5:3.